ESAT-6- and CFP-10-Specific Th1, Th22 and Th17 Cells in Tuberculous Pleurisy May Contribute to the Local Immune Response Against Mycobacterium Tuberculosis Infection

Scandinavian Journal of Immunology

Volumn 73, Issue 4, 2011, Pages 330-337

  Qiao, D ^a   Yang, B Y ^a   Li, L ^a   Ma, J J ^a   Zhang, X L ^b   Lao, S H ^b   Wu, C Y ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU CHEST HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; CD45RA ANTIGEN; CHEMOKINE RECEPTOR CCR7; CULTURE FILTRATE PROTEIN 10; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 22; L SELECTIN; MESSENGER RNA;

ADULT; AGED; ARTICLE; BCG VACCINATION; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; TH1 CELL; TH17 CELL; TH22 CELL; TUBERCULOUS PLEURISY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, BACTERIAL; ANTIGENS, CD; BACTERIAL PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOPHENOTYPING; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKINS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; PLEURAL EFFUSION; RECEPTORS, CCR7; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS; TH17 CELLS; TUBERCULOSIS, PLEURAL; YOUNG ADULT;

EID: 79952056291     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2011.02512.x     Document Type: Article

References (44)

1. WHO. Global Tuberculosis Control: Surveillance, Planning, Financing. Geneva: WHO, 2007(WHO/HTM/TB/2007.376).
2. Kaufmann SH. Recent findings in immunology give tuberculosis vaccines a new boost. Trends Immunol 2005;26:660-7.
3. Rook GA, Dheda K, Zumla A. Immune responses to tuberculosis in developing countries: implications for new vaccines. Nat Rev Immunol 2005;5:661-7.
4. + T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J Immunol 1993;151:518-25.
5. Ottenhoff TH, Kumararatne D, Casanova JL. Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria. Immunol Today 1998;19:491-4.
6. Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001;19:93-129.
7. Akahoshi M, Nakashima H, Miyake K et al. Influence of interleukin-12 receptor polymorphisms on tuberculosis. Hum Genet 2003;112:237-43.
8. Flynn JL, Chan J, Triebold KJ et al. An essential role for interferon-γ in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993;178:2249-54.
9. Newport MJ, Huxley CM, Huston S et al. A mutation in the interferon-γ-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996;335:1941-9.
10. Jouanguy E, Altare F, Lamhamedi S et al. Interferon-γ-receptor deficiency in an infant with fatal Bacille Calmette-Guerin infection. N Engl J Med 1996;335:1956-61.
11. Jouanguy E, Lamhamedi-Cherradi S, Altare F et al. Partial interferon-γ-receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guerin infection and a sibling with clinical tuberculosis. J Clin Invest 1997;100:2658-64.
12. Condos R, Rom WN, Schluger NW. Treatment of multidrug-resistant pulmonary tuberculosis with interferon-γ via aerosol. Lancet 1997;349:1513-5.
13. Pestka S, Krause CD, Sarkar D et al. Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 2004;22:929-79.
14. Renauld JC. Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators. Nat Rev Immunol 2003;3:667-76.
15. Kotenko SV, Izotova LS, Mirochnitchenko OV et al. Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rb) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes. J Biol Chem 2001;276:2725-32.
16. Wolk K, Kunz S, Witte E et al. IL-22 increases the innate immunity of tissues. Immunity 2004;21:241-54.
17. Sanjabi S, Zenewicz LA, Kamanaka M et al. Anti-inflammatory and pro-inflammatory roles of TGF-β, IL-10, and IL-22 in immunity and autoimmunity. Curr Opin Pharmacol 2009;9:447-53.
18. + T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 2007;8:369-77.
19. Khader SA, Pearl JE, Sakamoto K et al. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-γ responses if IL-12p70 is available. J Immunol 2005;175:788-95.
20. Umemura M, Yahagi A, Hamada S et al. IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection. J Immunol 2007;178:3786-96.
21. Wozniak TM, Ryan AA, Britton WJ. Interleukin-23 restores immunity to Mycobacterium tuberculosis infection in IL-12p40-deficient mice and is not required for the development of IL-17-secreting T cell responses. J Immunol 2006;177:8684-92.
22. Prabha C, Jalapathy KV, Matsa RP et al. Role of TNF-alpha in host immune response in tuberculous pleuritis. Curr Sci 2003;5:639-42.
23. Brodin P, De Jonge MI, Majlessi L et al. Functional analysis of early secreted antigenic target-6, the dominant T-cell antigen of Mycobacterium tuberculosis, reveals key residues involved in secretion, complex formation, virulence, and immunogenicity. J Biol Chem 2005;280:33953-9.
24. Collins HL, Kaufmann SH. The many faces of host responses to tuberculosis. Immunology 2001;103:1-9.
25. Sahiratmadja E, Alisjahbana B, De Boer T et al. Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment. Infect Immun 2007;75:820-9.
26. Arend SM, Geluk A, Van Meijgaarden KE et al. Antigenic equivalence of human T-cell responses to Mycobacterium tuberculosis-specific RD1-encoded protein antigens ESAT-6 and culture filtrate protein 10 and to mixtures of synthetic peptides. Infect Immun 2000;68:3314-21.
27. Zheng Y, Danilenko DM, Valdez P et al. Interleukin-22, a T (H) 17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007;445:648-51.
28. Wilson NJ, Boniface K, Chan JR et al. Development, cytokine profile, and function of human interleukin 17-producing helper T cells. Nat Immunol 2007;8:950-7.
29. Wolk K, Witte E, Reineke U et al. Is there an interaction between interleukin-10 and interleukin-22? Genes Immun 2005;6:8-18.
30. Aujla SJ, Chan YR, Zheng M et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 2008;14:275-81.
31. + T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005;6:1133-41.
32. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005;6:1123-32.
33. Vanaudenaerde BM, Dupont LJ, Wuyts WA et al. The role of interleukin-17 during acute rejection after lung transplantation. Eur Respir J 2006;27:779-87.
34. Molet S, Hamid Q, Davoine F et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 2001;108:430-8.
35. Snell GI, Levvey BJ, Zheng L et al. Interleukin-17 and airway inflammation: a longitudinal airway biopsy study after lung transplantation. J Heart Lung Transplant 2007;26:669-74.
36. Laan M, Palmberg L, Larsson K et al. Free, soluble interleukin-17 protein during severe inflammation in human airways. Eur Respir J 2002;19:534-7.
37. Lorgat F, Keraan MM, Ress SR. Cellular immunity in tuberculous pleural effusions: evidence of spontaneous lymphocyte proliferation and antigen specific accelerated responses to purified protein derivative (PPD). Clin Exp Immunol 1992;90:215-8.
38. Lorgat F, Keraan MM, Lukey PT et al. Evidence for in vivo generation of cytotoxic T cells. PPD-stimulated lymphocytes from tuberculous pleural effusions demonstrate enhanced cytotoxicity with accelerated kinetics of induction. Am Rev Respir Dis 1992;145:418-23.
39. Manca F, Rossi G, Valle MT et al. Limited clonal heterogeneity of antigen specific T cells localizing in the pleural space during mycobacterial infection. Infect Immun 1991;59:503-13.
40. Martin B, Hirota K, Cua DJ et al. Interleukin-17-producing γδ T cells selectively expand in response to pathogen products and environmental signals. Immunity 2009;31:321-30.
41. + T cells specific for Candida albicans are present in humans. Eur J Immunol 2009;39:1472-9.
42. + T cell subsets contribute to the human anti-mycobacterial immune response. J Immunol 2008;180:1962-70.
43. Annunziato F, Cosmi L, Santarlasci V et al. Phenotypic and functional features of human Th17 cells. J Exp Med 2007;204:1849-61.
44. + Treg cells inhibit human memory γδ T cells to produce IFN-γ in response to M tuberculosis antigen ESAT-6. Blood 2008;111:5629-36.